Patents by Inventor Nathaniel Gordon

Nathaniel Gordon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250141541
    Abstract: Techniques for communicating between a first satellite payload in an electronic distributed ledger network and a second satellite payload in the electronic distributed ledger network are presented. The techniques include: providing, by the first satellite payload and to the distributed ledger network, a request for a service; obtaining, by the first satellite payload, a service response from the second satellite payload and an indication of compliance with a policy concerning the service; determining, by the first satellite payload, and based on the indication of compliance, whether the service response conforms to the policy concerning the service; and acting on the service response, by the first satellite payload, based on the determining.
    Type: Application
    Filed: January 31, 2023
    Publication date: May 1, 2025
    Inventors: Gregory FALCO, Nathaniel GORDON
  • Publication number: 20190343963
    Abstract: A protease therapeutic comprising a Lysine-specific metalloprotease domain conjugated to a first targeting moiety.
    Type: Application
    Filed: April 21, 2017
    Publication date: November 14, 2019
    Inventors: Carole Urbach, Nathaniel Gordon
  • Publication number: 20080039341
    Abstract: The present invention provides unstructured recombinant polymers (URPs) and proteins containing one or more of the URPs. The present invention also provides microproteins, toxins and other related proteinaceous entities, as well as genetic packages displaying these entities. The present invention also provides recombinant polypeptides including vectors encoding the subject proteinaceous entities, as well as host cells comprising the vectors. The subject compositions have a variety of utilities including a range of pharmaceutical applications.
    Type: Application
    Filed: March 6, 2007
    Publication date: February 14, 2008
    Inventors: Volker Schellenberger, Willem Stemmer, Chia-wei Wang, Michael Scholle, Mikhail Popkov, Nathaniel Gordon, Andreas Crameri
  • Publication number: 20070218069
    Abstract: Anti-polyubiquitin monoclonal antibodies, and methods for using the antibodies, are provided.
    Type: Application
    Filed: December 14, 2006
    Publication date: September 20, 2007
    Inventors: Nathaniel Gordon, Robert Kelley, Anh Pham, Sarah Hymowitz
  • Publication number: 20060135430
    Abstract: The present invention relates to polypeptides that block BLyS signaling, nucleic acid molecules encoding the polypeptides, and compositions comprising the polypeptides. The present invention also relates to methods for treating an immune-related disease or cancer using the polypeptides and compositions of the invention. The present invention also relates to methods for identifying inhibitors of BLyS signaling.
    Type: Application
    Filed: November 30, 2005
    Publication date: June 22, 2006
    Applicant: GENENTECH, INC.
    Inventors: Andrew Chan, Nathaniel Gordon, Robert Kelley, Michael Koehler, Melissa Starovasnik